Chinese Colorectal Cancer Database
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorBeijing Friendship Hospital
About this trial
1. To establish the Chinese people's own clinical data database of colorectal cancer, reflecting the law and characteristics of colorectal cancer patients in China. 2. Based on colorectal cancer surgery, collect clinical data, especially data on clinical manifestations, complications, laboratory tests, auxiliary examinations, postoperative clinical effects, surgical complications, and colorectal cancer recurrence, so as to lead the direction of clinical practice and academic research of colorectal cancer surgery in China. It provides a certain basis for future research on colorectal cancer. 3. Provide academic consultation and data support to national health authorities.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adenocarcinoma of the colon by biopsy
tolerable to surgery
be able to understand and willing to participate in this trial with signature
Disqualifiers
can not tolerate the surgery
history of serious mental illness
the researchers believe the patients should not enrolled in
Trial population
colorectal cancer patients who are suitable and willing to accept the surgery and also agree with the trial
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Positive rate of circumferential resection margin (CRM) of the specimens
Circumferential resection margin (CRM) is the distance between the deepest point of tumor in the primary cancer and the margin of resection in the retroperitoneum or mesentery by pathological examination. CRM 0-1mm is defined as positive, while \>1mm is negative.
Time frame
10 days after surgery2
The grade score of the specimens integrity
shows the quality of the specimens: grade 1 is bad gross specimen which means incomplete mesorectum and pelvic fascia, and muscle layer can be see \>5mm; grade 3 is high quality gross specimen, which means the specimen is cylindrical, mesorectum and pelvic fascia are complete; grade 2 is between 1and 3.
Time frame
10 days after surgery3
The distance between lower tumor margin and the lower reaction margin
shows the oncological safety of the surgery by pathological examination. Reports should contain the distance between lower tumor margin and the lower reaction margin.
Time frame
10 days after surgery4
local recurrence rate
show the oncological efficacy by 3-year follow-up according to the NCCN guideline. Participants should report every follow-up examinations which prove tumor recurrence and/or metastasis or not.
Time frame
3 years after surgerySponsors and contacts
Click on the lead sponsor to view all of their trials.
Beijing Friendship Hospital
Lead sponsor
Beijing Chao Yang Hospital
Collaborator
Peking University People's Hospital
Collaborator
Peking University Cancer Hospital & Institute
Collaborator
Peking Union Medical College Hospital
Collaborator
The First Hospital of Jilin University
Collaborator
Ruijin Hospital
Collaborator
First Hospital of China Medical University
Collaborator
Source ClinicalTrials.gov